| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88261998 | FILING DATE | 01/15/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | EDWARDS, ALICIA COLLIN |
L.O. ASSIGNED | 115 |
PUB INFORMATION |
|||
| RUN DATE | 05/04/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 05/03/2019 | ||
| LITERAL MARK ELEMENT | HOOKIPA PHARMA | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | YES | 44D | NO |
| 44E | YES | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | HOOKIPA PHARMA |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Hookipa Biotech GmbH |
| ADDRESS | Helmut-Qualtinger-Gasse 2 Wien, 1030 |
| ENTITY | 99-gesellschaft mit beschränkter haftung (gmbh) |
| CITIZENSHIP | Austria |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical and veterinary preparations, in particular preparations for active and passive immunization in the nature of vaccines, including vaccines for infectious disease, cancer and autoimmune disease |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION TEXT | Treatment of materials for the manufacture of preparations for active and passive immunization in the nature of vaccines, including vaccines for infectious disease, cancer and autoimmune disease |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services related to active and passive immunization, namely, scientific research, pharmaceutical research and development, pharmaceutical testing, analysis, and evaluation, and industrial analysis and research related to vaccines, including vaccines for infectious disease, cancer and autoimmune disease |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 040 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) red and blue is/are claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "PHARMA" |
| DESCRIPTION OF MARK | The mark consists of the wording "HOOKIPA PHARMA" in red, to the right of which is a design consisting of three curved blue bands. |
| TRANSLATION | The wording "HOOKIPA" has no meaning in a foreign language. |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON European Union |
| APPLICATION NO. | 017934179 |
| APPLICATION FILING DATE | 07/24/2018 |
| FOREIGN REG NO. | 017934179 |
| FOREIGN REG DATE | 12/04/2018 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 07/24/2028 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 05/03/2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 013 |
| 05/03/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 012 |
| 05/03/2019 | ALIE | A | ASSIGNED TO LIE | 011 |
| 05/03/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 010 |
| 05/03/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 009 |
| 05/03/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 008 |
| 03/29/2019 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 007 |
| 03/29/2019 | GPRA | F | PRIORITY ACTION E-MAILED | 006 |
| 03/29/2019 | CPRA | R | PRIORITY ACTION WRITTEN | 005 |
| 03/28/2019 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 03/21/2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 02/06/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 01/18/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Angela R. Gott |
| CORRESPONDENCE ADDRESS | ANGELA R. GOTT JONES DAY 901 LAKESIDE AVENUE NORTH POINT CLEVELAND, OH 44114-1190 |
| DOMESTIC REPRESENTATIVE | NONE |